Abstract:Sir: We would like to thank Foissac et al. for sharing their experience and their human tissue model. The model they proposed is very interesting and is also meaningful for research of various types of vascular complications. Safe and effective dosage of hyaluronidase for treating hyaluronic acid–induced vascular embolism is a long-debated problem. Sall and Férard pointed out that varying hyaluronic acid products presented different sensitivity to hyaluronidase.1 Flynn et al. demonstrated that different brands of hyaluronic acid products of the same molecular weight class also respond to hyaluronidase differently.2 Therefore, we believe that accurate dosage of hyaluronidase may vary wildly according to the hyaluronic acid product used in actual clinical cases. The diameter of the vessel, location of obstruction, and amount of intravascular hyaluronic acid could also affect the outcome of hyaluronidase treatment. Regardless of the severity of the hyaluronic acid obstruction, it is imperative to begin treatment as soon as signs of vascular embolism are discovered. Local massage could help loosen the clot, which is beneficial when performed with our proposed method. Although allergic reaction of systemic use of hyaluronidase is an issue that should be considered, the benefit of the method can be greater than damage caused by severe hyaluronic acid vascular obstruction. Pillwein et al. added high-dose hyaluronidase to chemotherapy medication for patients with brain tumors.3 According to their results, allergic reactions of systemic hyaluronidase are rare in adults, with a 2 to 3 percent occurrence rate. Should allergic reactions occur, symptoms can improve quickly with immediate discontinuation of hyaluronidase and administration of prednisolone, epinephrine, and dimethindene maleate treatment.3 Urokinase is relatively safe, provided that the patient has no contraindications. Hyaluronidase and urokinase are best used together, as formation of red thrombus can worsen the embolism. We believe our proposed method is safe and feasible when administered under strict supervision, and it might be the sole solution when hyaluronic acid embolism occurs in locations unreachable by local hyaluronidase. DISCLOSURE The authors have no financial interest to declare in relation to the content of this communication. ACKNOWLEDGMENT This research was funded by the National Natural Science Foundation of China (nos. 81272128 and 81471878) and National 863 Key Projects (no. 2014AA020705). ChengAn Chiang, M.D., Ph.D.ShuangBai Zhou, M.D., Ph.D.Kai Liu, M.D., Ph.D.Department of Plastic and Reconstructive SurgeryShanghai Ninth People’s HospitalAffiliated to School of Medicine ShanghaiJiao Tong UniversityShanghai, People’s Republic of China

Superselective Arterial Hyaluronidase Thrombolysis is an Effective Treatment for Hyaluronic Acid-Induced Retinal Artery Occlusion: Study in a Rabbit Model

Superselective Arterial Hyaluronidase Thrombolysis is Not an Effective Treatment for Hyaluronic Acid–Induced Retinal Artery Occlusion: Study in a Rabbit Model

Efficacy of Superselective Intra-arterial Recanalization of Embolized Arteries Resulting from Facial Hyaluronic Acid Injection

Intravenous Hyaluronidase with Urokinase As Treatment for Rabbit Retinal Artery Hyaluronic Acid Embolism

Plasma Hyaluronan and Collateral Development in Patients with Coronary Artery Disease

Retinal Branch Artery Embolization Following Hyaluronic Acid Injection: A Case Report.

Intravenous Hyaluronidase with Urokinase As Treatment for Arterial Hyaluronic Acid Embolism.

Administration Method and Potential Efficacy of Hyaluronidase for Hyaluronic Acid Filler-Related Vision Loss: A Systematic Review.

Comparison of Intra-arterial and Subcutaneous Testicular Hyaluronidase Injection Treatments and the Vascular Complications of Hyaluronic Acid Filler.

Facial Artery Branch Thrombolysis for Nasal Vascular Embolism Induced by Hyaluronic Acid Injection

Reply: Intravenous Hyaluronidase with Urokinase As Treatment for Arterial Hyaluronic Acid Embolism

Biocompatibility and Efficacy of a Linearly Cross-Linked Sodium Hyaluronic Acid Hydrogel as a Retinal Patch in Rhegmatogenous Retinal Detachment Repairment

Exploring Super-Selective Intra-Arterial Thrombolysis for Autologous Fat Injection–Induced Vision Loss

Super-Selective Intra-arterial Thrombolytic Therapy for Peripheral Facial Paralysis After Postauricular Hyaluronic Acid Injection for the Esthetic Correction of Lying Ears

Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment

Injectable in situ cross-linking hyaluronan hydrogel for easier removal of posterior vitreous cortex in vitrectomy

Efficacy Evaluation of Tissue Plasminogen Activator with Anti-Vascular Endothelial Growth Factor Drugs for Submacular Hemorrhage Treatment: A Meta-Analysis

Embolization of Ophthalmic Artery Induced By Ear Hyaluronic Acid Injection

Hyaluronan‐Sphingosine Polymersomes for Treatment of Ocular Neovascularization: Synthesis and Evaluation

Concurrent Imaging and Clinical Study of the Efficacy of Hyaluronic Acid Injection for Knee Osteoarthritis: A Synovial Membrane Investigation with Ultrasound Imaging

Injectable cross-linked hyaluronic acid hydrogels with epigallocatechin gallate loading as vitreous substitutes